• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

MECHANISTIC STUDY OF APOPTOTIC CELL DEATH AND INVASION POTENTIAL USING SIGNAL TRANSDUCTION INHIBITORS IN THE ONCOGENE-TRANSFECTED HUMAN CELLS

Research Project

Project/Area Number 10670415
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

NAKANO Shuji  KYUSHU UNIV., FACULTY OF MEDICINE, ASSISTANT PROF., 医学部, 講師 (40164248)

Co-Investigator(Kenkyū-buntansha) NAKAMURA Minoru  KYUSHU UNIV., FAC.MED., INSTRUCTOR, 医学部, 助手 (40217906)
出原 賢二  九州大学, 医学部, 助手 (00270463)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 1999: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 1998: ¥2,100,000 (Direct Cost: ¥2,100,000)
KeywordsOncogene / apoptosis / signal transductione / Focal adhesion kinase / Rac / Rho / loss of anchorage-dependence / Src tyrosine kinase / Ras / rac / rho / ras
Research Abstract

Although src or ras oncogene induces transformation, their precise roles in the apoptotic machinery and invasion remain to be clarified. We examined the role of these oncogenes on the detachment-induced apoptosis termed anoikis and invasion potential, using HAG-1 human epithelial cell lines transfected with v-src or activated ras. Non-tumorigenic parental, mock-transfected, and ras-transfected HAG-1 cells underwent anoikis. By contrast, tumorigenic, v-src-transformed cells did not exhibit such apoptotic features. pp125^<FAK> focal adhesion kinase (FAK), was constitutively activated only in the v-src-transformed cells. Moreover, herbimycin A, a Src tyrosine kinase inhibitor, reduced tyrosyl phosphorylation of pp125^<FAK>, and reversed resistance to anoikis. These data suggest that pp60^<v-src> may substitute for integrin in the activation of pp125^<FAK>, thereby evading anoikis, and that the association of pp60^<src> with FAK might be required for acquisition of anchorage-independence. … More The functional role of ras in the acquisition of fully neoplastic potentials by v-src-transformed human gallbladder HAG/src3-1 cells, were investigated by introducing adenoviral vector containing dominant negative Ras (DN/Ras) into these cells. The anchorage-independent growth of the HAG/src3-1 was inhibted by DN/Ras by 93%. The HAG/src3-1 cells transfected with DN/ras failed to form tumors. Thus, v-src might requires a Ras-MAP kinase signaling cascade in the acquisition of tumorigenic potential. To examine the potential role of Rac, a small GTPase binding protein which acts downstream of Ras, experiments using adenovirus vectors containing DN/Ras or dominant negative Rac (DN/Rac), were performed. The data indicated that both DN/Ras and DN/Rac reduced the invasive potential of src-transfected cells by 60% and 99%, respectively, as compared to AdCALacZ containing β-gal gene as a control. Moreover, DN/Rac suppressed completely the tumorigenic potentials of src-transfected cells in nude mice. These results suggest that Src, Ras, Rac, all appeared to participate in the invasion processes, and that Rac may act downstream of these signaling pathways of invasion and tumorigenicity. Less

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (28 results)

All Other

All Publications (28 results)

  • [Publications] Masumoto N: "v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells"International Journal of Cancer. 80. 731-737 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Okuma K: "Host range of HTLV-1 analyzed by a cell fusion-dependent reporter gene activation assay"Virology. 254. 235-244 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Boudny V: "Expression of activated c-erbB-2 oncogene induces sensitivity to cisplatin in human gallbladder denocarcinoma cells"Anticancer Research. 19. 5203-5206 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Tokumitsu Y: "Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras"Journal of Cellular Physiology. 183. 221-227 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kato K: "Structure and functional analysis of the human STAT3 gene promoter : alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells"Biochim Biophys Acta. 1493. 91-100 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Koizumi W: "Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer"Oncology. 58. 191-197 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 中野修治: "分子がん治療 シグナル伝達からみたがんの分子機構と治療への応用"先端医学社. 10 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Murakami Y, Nakano S, Niho Y, Hamasaki N, Izuhara K: "Constitutive activation of Jak-2 and Tyk-2 in a v-src-transformed human gallbladder adenocarcinoma cell line."J.Cell.Physiol.. 175. 220-228 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Fujishima H, Nakano S, Tatsumoto T, Masumoto N, Niho Y: "Interferon-a and -g inhibit the growth and neoplastic potential of v-src-transformed human epithelial cells by reducing src tyrosine kinase activity."International J.Cancer. 76. 423-429 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Masumoto N, Nakano S, Fujishima H, Kohno K, Niho Y: "v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells."International J.Cancer. 80. 731-737 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Okuma K, Nakamura M, Nakano S, Tanaka Y, and Niho Y: "Identification of a novel bovime serum protein which is involved in human T-cell leukemia virus type I (HTLV-I)-induced syncytium formation."Archives of Virology. 144. 1-18 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Oknma K, Nakamura M, Nakano S, Niho Y, Matsuura Y: "Host Range of Human T-Cell Leukemia Virus Type I Analyzed by a Cell Fusion-Dependent Reporter Gene Activation Assay."Virology. 254. 235-244 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Boudny V, Murakami Y, Nakano S, Niho Y: "Expression of activated c-erbB-2 oncogene induces sensitivity to cisplatin in human gallbladder adenocarcinoma cells."Anticancer Res.. 19. 5203-5206 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Tokumitsu Y, Mori M, Tanaka S, Akazawa K, Nakano S, Niho Y: "Prognostic significance of polo-like kinase in esophageal carcinoma."International Journal of Oncology. 15. 687-692 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Tokumitsu Y, Nakano S, Ueno H, Niho Y: "Suppression of malignant growth potentials of v-src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras."J.Cell.Physiology. 183. 221-227 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Koizumi W, Kurihara M, Nakano S, Hasegawa K: "Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer."Oncology. 58(3). 191-197 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kato K, Nomoto M, Izumi H, Nakano S, Niho Y Kohno K.: "Structure and functional analysis of the human STAT3 gene promoter : alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells."Biochim Biophys Acta.. 1493. 91-100 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Fujishima H: "IFN alpha and gamma inhibit the neoplastic potential of v-src-transformed cells"International Journal of Cancer. 76. 423-429 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] Masumoto N: "v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells"International Journal of Cancer. 80. 731-737 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Okuma K: "Host range of HTLV-1 analyzed by a cell fusion-dependent reporter gene activation assay"Virology. 254. 235-244 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tokumitsu Y: "Prognostic significance of polo-like kinase in esophageal carcinoma."Int. J. Oncology. 15. 687-692 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Boudny V: "Expression of activated c-erbB-2 oncogene induces sensitivity to cisplatin in human gallbladder adenocarcinoma cells."Anticancer Research. 19. 5203-5206 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tokumitsu Y: "Suppression of malignant growth potentials v-src-transformed human gallbladder adenocarcinoma cells by adenovirus-mediated dominant negative H-Ras"Journal of Cell. Physiology. 175(印刷中). (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Murakami Y: "Constitutive activation of Jak-2 and Tyk-2 in v-Src-transformed HAG-1 human cells" Journal of Cellular Physiology. 175. 220-228 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Fujishima H: "IFN alpha and gamma inhibit the neoplastic potential of v-src-transformed cells" International Journal of Cancer. 76. 423-429 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Masumoto N: "v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells" International Journal of Cancer. 80. 731-737 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Okuma K: "Host range of HTLV-1 analyzed by a cell fusion-dependent reporter gene activation assay" Virology. 254. 235-244 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Okuma K: "Identification of a novel bovine serum protein involved in HTLV-1 omduced synsytium-" Archives of Virology. 144. 1-18 (1999)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi